Skip to content
Menu
  • Products
    • Pathology
      • Agilent Dako
      • Milestone SpA
      • pfm medical ag
      • Atom Scientific Limited
      • Guangdong Jinquan Medical Technology Co.,Ltd
      • EXAKT Advanced Technologies GmbH
      • Microptic SL
    • Toxicology
      • Randox Toxicology
    • Radiology
      • GE Healthcare
  • Business Partners
  • Valuable Clients
  • About Us
  • News Room
  • Contact Us
  • Search
  • Products
    • Pathology
      • Agilent Dako
      • Milestone SpA
      • pfm medical ag
      • Atom Scientific Limited
      • Guangdong Jinquan Medical Technology Co.,Ltd
      • EXAKT Advanced Technologies GmbH
      • Microptic SL
    • Toxicology
      • Randox Toxicology
    • Radiology
      • GE Healthcare
  • Business Partners
  • Valuable Clients
  • About Us
  • News Room
  • Contact Us
Meximp Technologies

News Room

2

Nov 21

Agilent Names John Palma to Lead Global Medical Affairs Organization

Agilent Dako
Agilent Names John Palma to Lead Global Medical Affairs Organization Agilent Technologies, Inc. (NYSE: A) today announced that John Palma...
Read More

21

Oct 21

Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Agilent Dako
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction,...
Read More

13

Oct 21

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

Agilent Dako
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer Agilent Technologies Inc. (NYSE:...
Read More

29

Sep 21

GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases

GE Healthcare
GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases GE...
Read More

17

Sep 21

Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system

pfm medical ag
Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system The ClearCoast™ MRI system makes it...
Read More

17

Sep 21

New name: ClearSight™ has become ClearCoast™

pfm medical ag
New name: ClearSight™ has become ClearCoast™ ClearCut Medical Ltd. has changed the name of its diffusion-weighted MRI technology for intraoperative...
Read More

16

Sep 21

A Deep-Learning Model May Help Predict Lung Cancer Survival and Outcomes

GE Healthcare
A Deep-Learning Model May Help Predict Lung Cancer Survival and Outcomes A deep-learning model developed using serial image scans of...
Read More

2

Sep 21

Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement

Agilent Dako
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement Agilent Technologies Inc. (NYSE: A) today announced the signing of a...
Read More

23

Aug 21

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer

Agilent Dako
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer PD-L1 IHC 22C3 pharmDx can now be used...
Read More

10

Aug 21

ESP Virtual Congress 2021

Milestone Srl
ESP Virtual Congress 2021 Milestone will participate to the 33nd European Congress of Pathology, from 29th to 31st August 2021,...
Read More
« Previous 1 2 3 4 5 … 8 Next »

Latest News

  • Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
    05-Jun-2026, Agilent Dako
  • Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
    26-Mar-2026, Agilent Dako
  • Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
    09-Mar-2026, Agilent Dako
  • Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
    10-Mar-2025, Agilent Dako
  • World Cancer Day 2025 How Agilent is Driving Advanced Cancer Diagnostics
    04-Feb-2025, Agilent Dako
  • Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
    10-Dec-2024, Agilent Dako
  • Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
    14-Nov-2023, Agilent Dako
  • Agilent Receives European IVDR Certification for Companion Diagnostic Assay
    24-Aug-2023, Agilent Dako
  • Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia
    07-Aug-2023, Agilent Dako
  • Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
    10-Jul-2023, Agilent Dako

---------------------

---------------------

---------------------

---------------------

---------------------

---------------------

---------------------

---------------------

Connect with Meximp

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Copyright © 2026 Meximp Technologies. All Rights Reserved.

Codilight Theme by FameThemes